Patient Characteristics
Characteristic . | CSA . | ATG + CSA . | P . | ||
---|---|---|---|---|---|
Median . | Range . | Median . | Range . | ||
No. of patients | 61 | 54 | |||
Age (yr) | 35 | 17-84 | 29 | 1-67 | .04 |
Sex ratio (male:female) | 36:24 | 24:30 | .09 | ||
Follow-up period (d) | 343 | 19-1,454 | 365 | 21-1,227 | .5 |
Hemoglobin (g/dL) | 8.1 | 2.9-11.5 | 7.9 | 3.9-13.0 | .2 |
Neutrophil count (×109/L) | 1.0 | 0.5-2.6 | 0.9 | 0.5-4.8 | .4 |
Platelet count (×109/L) | 20 | 2-63 | 15 | 1-58 | .01 |
Characteristic . | CSA . | ATG + CSA . | P . | ||
---|---|---|---|---|---|
Median . | Range . | Median . | Range . | ||
No. of patients | 61 | 54 | |||
Age (yr) | 35 | 17-84 | 29 | 1-67 | .04 |
Sex ratio (male:female) | 36:24 | 24:30 | .09 | ||
Follow-up period (d) | 343 | 19-1,454 | 365 | 21-1,227 | .5 |
Hemoglobin (g/dL) | 8.1 | 2.9-11.5 | 7.9 | 3.9-13.0 | .2 |
Neutrophil count (×109/L) | 1.0 | 0.5-2.6 | 0.9 | 0.5-4.8 | .4 |
Platelet count (×109/L) | 20 | 2-63 | 15 | 1-58 | .01 |